Ad is loading...
MENU

RDY Stock Tickeron detected bearish Stock Pattern: Three Falling Peaks RDY on October 03, 2024, netting in a 6.77% gain over 1 month

A.I.dvisor
at Tickeron.com
Loading...
+6.77% Gain from a Successful pattern Three Falling Peaks
RDY - Dr. Reddy's Laboratories Ltd
Tickeron
Ticker: RDY
Company: Dr. Reddy's Laboratories
Gain from shortening: +6.77%
Confirmed: 10/03/24
Succeeded: 11/04/24
Total length: 42 days
On September 23, 2024, A.I.dvisor detected a Three Falling Peaks Pattern (Bearish) for Dr. Reddy's Laboratories Ltd (RDY, $3.97). 10 days later, on October 03, 2024, A.I.dvisor confirmed the Bearish pattern, setting a target price of the stock. On November 04, 2024, the stock hit the target price of $73.23 – resulting in a gain for traders who shorted the stock on the pattern detection date.

RDY's Indicator enters downward trend

The Aroon Indicator for RDY entered a downward trend on November 04, 2024. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 151 similar instances where the Aroon Indicator formed such a pattern. In of the 151 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 25, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on RDY as a result. In of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for RDY turned negative on October 24, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 40 similar instances when the indicator turned negative. In of the 40 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RDY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

RDY moved above its 50-day moving average on November 05, 2024 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for RDY crossed bullishly above the 50-day moving average on November 05, 2024. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +31 3-day Advance, the price is estimated to grow further. Considering data from situations where RDY advanced for three days, in of 323 cases, the price rose further within the following month. The odds of a continued upward trend are .

RDY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RDY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.833) is normal, around the industry mean (57.643). P/E Ratio (19.682) is within average values for comparable stocks, (89.101). Projected Growth (PEG Ratio) (4.879) is also within normal values, averaging (2.947). Dividend Yield (0.007) settles around the average of (0.122) among similar stocks. P/S Ratio (3.786) is also within normal values, averaging (19.160).

View a ticker or compare two or three
RDY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of pharmaceuticals

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Generic
Address
8-2-337, Road No. 3
Phone
+91 4049002900
Employees
25863
Web
https://www.drreddys.com